Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Main characters of studies included in the meta-analysis (TLR-9 gene rs5743836)

From: The relationship between toll-like receptors 9 gene rs5743836 polymorphism and lymphoma risk: a meta-analysis

Author

Year

Ethnicity

Sample size

 

Cases

 

Controls

NOS score

Lymphoma types

HWE test for controls

Case

Control

TT

TC

CC

T

C

TT

TC

CC

T

C

Nieters

2006

German

678

667

 

507

156

15

1170

186

 

475

181

11

1131

203

8

lymphoma

0.182

Carvalho

2012

Portuguese

797

1160

 

551

244

2

1346

248

 

934

217

9

2085

235

8

B-cell NHL

0.349

Carvalho

2012

Italian

494

468

 

345

135

14

825

163

 

379

81

8

839

97

8

B-cell NHL

0.139

Carvalho

2012

US

801

972

 

579

209

13

1367

235

 

674

275

23

1623

321

8

B-cell NHL

0.415

Rahman

2014

Egypt

100

100

 

41

58

1

140

60

 

74

26

0

174

26

8

B-cell NHL

0.135

Nielsen

2015

North Denmark

355

307

    

213

47

    

412

56

6

B-cell NHL

> 0.05

Al-Khatib

2022

Arab Jordanian

130

234

 

87

39

4

593

65

 

183

46

5

523

85

8

HL

0.306

  1. Note: NHL, non-Hodgkin lymphoma; cHL, classical Hodgkin lymphoma; HL, Hodgkin lymphoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us